Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
531 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2018
532 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
 		Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2018
533 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		Department of Clinical Pathology Dr. Samar Muhammad mansour 2018
534 Comparison of nebulised dexmedetomidine,
ketamine, or midazolam for premedication in
preschool children undergoing bone marrow biopsy 		Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2018
535 Frequency of ABCB1 Polymorphisms in Breast Cancer Patients in South Egypt Cancer Institute by High-Resolution Melting Curve Analysis
(Pilot Study) 		Department of Clinical Pathology Dina Ismeil Abd Elrazik 2018
536 Frequency of ABCB1 Polymorphisms in Breast Cancer Patients in South Egypt Cancer Institute by High-Resolution Melting Curve Analysis
(Pilot Study) 		Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2018
537 epidural dexmedetomidine infusion for
perioperative analgesia in patients undergoing
abdominal cancer surgery: randomized trial 		Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2018
538 Which is better for pain reduction during transrectal ultrasound-guided biopsy of the prostate: Intravenous diazepam, local periprostatic nerve block, or combination? controlled randomized study Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2018
539 New Look on Ureterocolic Diversion with Adjuvant Radiotherapy; SECI (South Egypt Cancer Institute) Experience Department of Surgical Oncology Ahmed Mokhtar Abdel- Rahim Abdel-Moneem 2018
540 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2018